Precigen (PGEN) Revenue (2012 - 2026)
Precigen (PGEN) reported Revenue of $23.3 million for Q1 2026, up 1633.93% year-over-year from $1.3 million in Q1 2025, and up 409.35% quarter-over-quarter from $4.6 million in Q4 2025.
Precigen (PGEN) Revenue (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Revenue data on file, last reported at $23.3 million in Q1 2026.
- Revenue for Q1 2026 came in at $23.3 million, up 1633.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.9 million (up 540.69% YoY), and the FY2025 annual result was $9.7 million, up 146.73% from the prior year.
- Revenue advanced to $23.3 million in Q1 2026 per PGEN's latest filing, from $4.6 million in the prior quarter.
- Over five years, Revenue peaked at $23.3 million in Q1 2026 and troughed at -$14.3 million in Q4 2022.
- A 5-year average of $2.0 million and a median of $1.3 million in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2023 and 2024: Revenue slumped 99.94% in 2023, then soared 88500.0% in 2024.
- A 5-year view of Revenue shows it stood at -$14.3 million in 2022, then soared by 108.58% to $1.2 million in 2023, then increased by 17.83% to $1.4 million in 2024, then soared by 215.48% to $4.6 million in 2025, then soared by 409.35% to $23.3 million in 2026.
- Business Quant data shows PGEN's Revenue at $23.3 million in Q1 2026, $4.6 million in Q4 2025, and $34000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 23.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.25 Mn |
| Dec 31, 2025 | 4.57 Mn |
| Jun 30, 2025 | 34,000.00 |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 886,000.00 |
| Jun 30, 2024 | 673,000.00 |
| Mar 31, 2024 | 138,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1.77 Mn |
| Mar 31, 2023 | 324,000.00 |
| Dec 31, 2022 | -14.31 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 5.51 Mn |
| Dec 31, 2021 | -10.21 Mn |
| Sep 30, 2021 | 3.33 Mn |
| Jun 30, 2021 | 3.82 Mn |
| Mar 31, 2021 | 24.51 Mn |